Общедоступные статьи - Thomas VanasscheПодробнее...
11 статей недоступны нигде
Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists
N De Crem, K Peerlinck, T Vanassche, K Vanheule, B Debaveye, ...
Thrombosis research 136 (4), 749-753, 2015
Финансирование: Research Foundation (Flanders)
Fibrin formation by staphylothrombin facilitates Staphylococcus aureus-induced platelet aggregation
T Vanassche, A Kauskot, J Verhaegen, WE Peetermans, J van Ryn, ...
Thrombosis and haemostasis 107 (06), 1107-1121, 2012
Финансирование: Research Foundation (Flanders)
Coagulase activity by Staphylococcus aureus: a potential target for therapy?
M Peetermans, P Verhamme, T Vanassche
Seminars in thrombosis and hemostasis 41 (04), 433-444, 2015
Финансирование: Research Foundation (Flanders)
Targeting coagulase activity in Staphylococcus aureus bacteraemia: a randomized controlled single-centre trial of staphylothrombin inhibition
M Peetermans, L Liesenborghs, K Peerlinck, E Van Wijngaerden, ...
Thrombosis and haemostasis 118 (05), 818-829, 2018
Финансирование: Research Foundation (Flanders)
Dextran sulfate triggers platelet aggregation via direct activation of PEAR1
C Vandenbriele, Y Sun, M Criel, K Cludts, S Van Kerckhoven, B Izzi, ...
Platelets 27 (4), 365-372, 2016
Финансирование: Research Foundation (Flanders)
Partial versus complete factor VIII inhibition in a mouse model of venous thrombosis
J Emmerechts, T Vanassche, S Loyen, I Van Linthout, K Cludts, A Kauskot, ...
Thrombosis research 129 (4), 514-519, 2012
Финансирование: Research Foundation (Flanders)
Clinical presentation and outcomes of patients with cancer-associated isolated distal deep vein thrombosis
JP Galanaud, J Trujillo-Santos, B Bikdeli, L Bertoletti, P Di Micco, ...
Journal of Clinical Oncology 42 (5), 529-537, 2024
Финансирование: American Heart Association, Canadian Institutes of Health Research
Factor XI inhibitors: potential role in end-stage kidney disease
M Ades, C Simard, T Vanassche, P Verhamme, J Eikelboom, ...
Seminars in Nephrology 43 (6), 151484, 2023
Финансирование: Fonds de recherche du Québec - Santé
Consensus validation of a screening tool for cardiovascular pharmacotherapy in geriatric patients: the RASP_CARDIO list (Rationalization of Home Medication by an Adjusted STOPP …
H De Schutter, J Hias, L Hellemans, K Walgraeve, J Tournoy, ...
European Geriatric Medicine 13 (6), 1467-1476, 2022
Финансирование: Research Foundation (Flanders)
Heparin dosing in patients with Impella-supported cardiogenic shock
C Vandenbriele, R M'Pembele, L Dannenberg, D Metzen, S Zako, ...
International Journal of Cardiology 399, 131690, 2024
Финансирование: German Research Foundation
Comment on: Anti-Coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions
L Van der Linden, T Vanassche, L Van Aelst, P Verhamme
Clinical Pharmacokinetics 63 (3), 395-396, 2024
Финансирование: Research Foundation (Flanders)
71 статья доступна в некоторых источниках
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
J Steffel, P Verhamme, TS Potpara, P Albaladejo, M Antz, L Desteghe, ...
European heart journal 39 (16), 1330-1393, 2018
Финансирование: Federal Ministry of Education and Research, Germany
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ...
The Lancet 391 (10117), 219-229, 2018
Финансирование: American Heart Association
Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant
JD Douketis, AC Spyropoulos, J Duncan, M Carrier, G Le Gal, AJ Tafur, ...
JAMA internal medicine 179 (11), 1469-1478, 2019
Финансирование: Heart and Stroke Foundation of Canada
Embolic strokes of undetermined source: prevalence and patient features in the ESUS Global Registry
KS Perera, T Vanassche, J Bosch, M Giruparajah, B Swaminathan, ...
International Journal of Stroke 11 (5), 526-533, 2016
Финансирование: UK Medical Research Council
Adhesion of Staphylococcus aureus to the vessel wall under flow is mediated by von Willebrand factor–binding protein
J Claes, T Vanassche, M Peetermans, L Liesenborghs, C Vandenbriele, ...
Blood, The Journal of the American Society of Hematology 124 (10), 1669-1676, 2014
Финансирование: Research Foundation (Flanders)
Staphylococcus aureus endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves
L Liesenborghs, S Meyers, M Lox, M Criel, J Claes, M Peetermans, ...
European heart journal 40 (39), 3248-3259, 2019
Финансирование: US National Institutes of Health, Research Foundation (Flanders)
Coagulation: At the heart of infective endocarditis
L Liesenborghs, S Meyers, T Vanassche, P Verhamme
Journal of Thrombosis and Haemostasis 18 (5), 995-1008, 2020
Финансирование: Research Foundation (Flanders)
Global survey of the frequency of atrial fibrillation–associated stroke: Embolic Stroke of Undetermined Source Global Registry
KS Perera, T Vanassche, J Bosch, B Swaminathan, H Mundl, ...
Stroke 47 (9), 2197-2202, 2016
Финансирование: UK Medical Research Council
Clumping factor A, von Willebrand factor‐binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall
J Claes, L Liesenborghs, M Peetermans, TR Veloso, D Missiakas, ...
Journal of Thrombosis and Haemostasis 15 (5), 1009-1019, 2017
Финансирование: US National Institutes of Health, Research Foundation (Flanders)
Информация о публикациях и финансировании собрана автоматически.